Exelixis | Zobowiązania Handlowe



Trade Creditors Zmiana Data
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Amgen USD 2.41B 498M 2025-03
AstraZeneca 22.54B 79M 2025-03
Bayer EUR 6.59B 931M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Cytokinetics USD 13.94M 6.43M 2025-03
Eisai JPY 91.57B 27.04B 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Exelixis USD 42.84M 4.65M 2025-04
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
MacroGenics USD 5.01M 1.6M 2024-12
Merck USD 3.78B 295M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
Sanofi 7.55B 118M 2024-12
Takeda JPY 475.54B 15.36B 2025-03
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Xencor USD 16.19M 568K 2025-03



Exelixis Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.